APOE and TREM2 regulate amyloid-responsive microglia in Alzheimer’s disease

References 76

1. 1.
   Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 · 2016

   Corrected
2. 2.

   Scheff SW and Price DA, Synapse loss in the temporal lobe in Alzheimer’s disease. Ann Neurol, 1993 33(2): p. 190–199.

   Not in our library10.1002/ana.410330209

3. 3.

   Terry RD,, Physical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol, 1991 30(4): p. 572–80.

   Not in our library10.1002/ana.410300410

4. 4.

   Glenner GG and Wong CW, Alzheimer’s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochemical and biophysical research communications, 1984 120(3): p. 885–90.

   Not in our library10.1016/s0006-291x(84)80190-4

5. 5.

   Thal DR,, Phases of Aβ-deposition in the human brain and its relevance for the development of AD. Neurology, 2002 58(12): p. 1791–1800.

   Not in our library10.1212/wnl.58.12.1791

6. 6.

   Lambert JC,, Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nature genetics, 2013 45(12): p. 1452–8.

   Not in our library10.1038/ng.2802

7. 7.
   Late onset Alzheimer’s disease genetics implicates microglial pathways in disease risk · 2017

   No notice
8. 8.

   Guerreiro R,, TREM2 Variants in Alzheimer’s Disease. New England Journal of Medicine, 2012 368(2): p. 117–127.

   Not in our library10.1056/nejmoa1211851

9. 9.

   Jonsson T,, Variant of TREM2 Associated with the Risk of Alzheimer’s Disease. New England Journal of Medicine, 2012 368(2): p. 107–116.

   Not in our library10.1056/nejmoa1211103

10. 10.

    Kunkle BW,, Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing. Nature genetics, 2019 51(3): p. 414–430.

    Not in our library10.1038/s41588-019-0358-2

11. 11.

    Neu SC,, Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer Disease: A Meta-analysis. JAMA Neurology, 2017 74(10): p. 1178–1189.

    Not in our library10.1001/jamaneurol.2017.2188

12. 12.

    Sims R,, Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer’s disease. Nature Genetics, 2017 49(9): p. 1373–1384.

    Not in our library10.1038/ng.3916

13. 13.

    Kleinberger G,, TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis. Sci Transl Med, 2014 6(243): p. 243ra86.

    Not in our library10.1126/scitranslmed.3009093

14. 14.

    Keren-Shaul H,, A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease. Cell, 2017 169(7): p. 1276–1290.e17.

    Not in our library10.1016/j.cell.2017.05.018

15. 15.
    Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders · 2016

    No notice
16. 16.

    Kim J, Basak JM, and Holtzman DM, The Role of Apolipoprotein E in Alzheimer’s Disease. Neuron, 2009 63(3): p. 287–303.

    Not in our library10.1016/j.neuron.2009.06.026

17. 17.

    Mauch DH,, CNS synaptogenesis promoted by glia-derived cholesterol. Science, 2001 294(5545): p. 1354–7.

    Not in our library10.1126/science.294.5545.1354

18. 18.

    Pfrieger FW, Cholesterol homeostasis and function in neurons of the central nervous system. Cell. Mol. Life Sci, 2003 60: p. 1158–1171.

    Not in our library10.1007/s00018-003-3018-7

19. 19.

    Grehan S, Tse E, and Taylor JM, Two Distal Downstream Enhancers Direct Expression of the Human Apolipoprotein E Gene to Astrocytes in the Brain. Journal of Neuroscience, 2001 21(3): p. 812–822.

    Not in our library10.1523/jneurosci.21-03-00812.2001

20. 20.

    Mahley RW, Weisgraber KH, and Huang Y, Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer’s disease. Proceedings of the National Academy of Sciences of the United States of America, 2006 103(5): p. 5644–5651.

    Not in our library10.1073/pnas.0600549103

21. 21.

    Ulrich JD,, ApoE facilitates the microglial response to amyloid plaque pathology. The Journal of Experimental Medicine, 2018 215(4): p. 1047–1058.

    Not in our library10.1084/jem.20171265

22. 22.

    Sala Frigerio C,, The Major Risk Factors for Alzheimer’s Disease: Age, Sex, and Genes Modulate the Microglia Response to Aβ Plaques. Cell Reports, 2019 27(4): p. 1293–1306.e6.

    Not in our library10.1016/j.celrep.2019.03.099

23. 23.

    Zhao Y,, TREM2 Is a Receptor for beta-Amyloid that Mediates Microglial Function. Neuron, 2018 97(5): p. 1023–1031.e7.

    Not in our library10.1016/j.neuron.2018.01.031

24. 24.

    Toledo JB,, A platform for discovery: The University of Pennsylvania Integrated Neurodegenerative Disease Biobank. Alzheimer’s & dementia: the journal of the Alzheimer’s Association, 2014 10(4): p. 477–484 e1.

    Not in our library10.1016/j.jalz.2013.06.003

25. 25.
    SCANPY: large-scale single-cell gene expression data analysis · 2018

    No notice
26. 26.

    Blondel VD, Guillaume JL, Lambiotte R, Lefebvre E, Fast unfolding of communities in large networks. Journal of Statistical Mechanics: Theory and Experiment, 2008 2008(10).

    Not in our library

27. 27.

    Jakel S,, Altered human oligodendrocyte heterogeneity in multiple sclerosis. Nature, 2019 566(7745): p. 543–547.

    Not in our library10.1038/s41586-019-0903-2

28. 28.

    Mi H,, Protocol Update for large-scale genome and gene function analysis with the PANTHER classification system (v.14.0). Nature protocols, 2019 14(3): p. 703–721.

    Not in our library10.1038/s41596-019-0128-8

29. 29.
    Cell-specific network constructed by single-cell RNA sequencing data · 2019

    No notice
30. 30.
    MetaCell: analysis of single-cell RNA-seq data using K-nn graph partitions · 2019

    No notice
31. 31.

    Liu F,, Global spectral clustering in dynamic networks. Proceedings of the National Academy of Sciences of the United States of America, 2018 115(5): p. 927–932.

    Not in our library10.1073/pnas.1718449115

32. 32.

    Trapnell C,, The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nature Biotechnology, 2014 32: p. 381.

    Not in our library10.1038/nbt.2859

33. 33.
    ForceAtlas2, a Continuous Graph Layout Algorithm for Handy Network Visualization Designed for the Gephi Software · 2014

    No notice
34. 34.
    The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019 · 2018

    No notice
35. 35.
    QuPath: Open source software for digital pathology image analysis · 2017

    No notice
36. 36.

    Jack CR Jr, Bennett DA, Blennow K, NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease. Alzheimers Dement. 2018;14(4):535–562

    Not in our library10.1016/j.jalz.2018.02.018

37. 37.
    Deep learning enables accurate clustering with batch effect removal in single-cell RNA-seq analysis · 2020

    No notice
38. 38.

    Streit WJ,, Dystrophic microglia in the aging human brain. Glia, 2004 45(2): p. 208–212.

    Not in our library10.1002/glia.10319

39. 39.

    Lopes KO, Sparks DL, and Streit WJ, Microglial dystrophy in the aged and Alzheimer’s disease brain is associated with ferritin immunoreactivity. Glia, 2008 56(10): p. 1048–1060.

    Not in our library10.1002/glia.20678

40. 40.

    Kristiansen M,, Identification of the haemoglobin scavenger receptor. Nature, 2001 409(6817): p. 198–201.

    Not in our library10.1038/35051594

Cited by papers we hold 17

• Microglial mechanisms drive amyloid-β clearance in immunized patients with Alzheimer’s disease · 2025
  Corrected
• Neurodegenerative Disease Tauopathies · 2024
  No notice
• Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets · 2023
  No notice
• Human microglia show unique transcriptional changes in Alzheimer’s disease · 2023
  No notice
• APOE modulates microglial immunometabolism in response to age, amyloid pathology, and inflammatory challenge · 2023
  No notice
• An aging, pathology burden, and glial senescence build-up hypothesis for late onset Alzheimer’s disease · 2023
  No notice
• hdWGCNA identifies co-expression networks in high-dimensional transcriptomics data · 2023
  No notice
• Guidelines for bioinformatics of single-cell sequencing data analysis in Alzheimer’s disease: review, recommendation, implementation and application · 2022
  Not checked
• ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies · 2022
  No notice
• TREM2 dependent and independent functions of microglia in Alzheimer’s disease · 2022
  No notice
• APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer’s disease pathology and brain diseases · 2022
  No notice
• Iron loading is a prominent feature of activated microglia in Alzheimer’s disease patients · 2021
  No notice
• Diverse human astrocyte and microglial transcriptional responses to Alzheimer’s pathology · 2021
  No notice
• Microglia in Neuroinflammation and Neurodegeneration: From Understanding to Therapy · 2021
  No notice
• Microglia in Alzheimer’s Disease: A Target for Therapeutic Intervention · 2021
  No notice
• Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease · 2021
  No notice
• Phospholipids of APOE lipoproteins activate microglia in an isoform-specific manner in preclinical models of Alzheimer’s disease · 2021
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.